메뉴 건너뛰기




Volumn 20, Issue 5, 2014, Pages 646-654

Antithymocyte Globulin before Allogeneic Stem Cell Transplantation for Progressive Myelodysplastic Syndrome: A Study from the French Society of Bone Marrow Transplantation and Cellular Therapy

(26)  Duléry, Rémy a   Mohty, Mohamad b,c,d   Duhamel, Alain e   Robin, Marie f   Beguin, Yves g   Michallet, Mauricette h   Vigouroux, Stéphane i   Lioure, Bruno j   Garnier, Alice k   El Cheikh, Jean l   Bulabois, Claude Eric m   Huynh, Anne n   Bay, Jacques Olivier o   Daguindau, Etienne p   Ceballos, Patrice q   Clément, Laurence r   Dauriac, Charles s   Maillard, Natacha t   Legrand, Faezeh u   Cornillon, JérÔme v   more..

d INSERM   (France)

Author keywords

Allogeneic stem cell transplantation; Antithymocyte globulin; Conditioning regimen; Graft versus host disease; Myelodysplastic syndrome

Indexed keywords

BUSULFAN; THYMOCYTE ANTIBODY; LYMPHOCYTE ANTIBODY; MYELOABLATIVE AGENT;

EID: 84897957278     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.01.016     Document Type: Article
Times cited : (23)

References (37)
  • 1
    • 10744229703 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia
    • Kröger N., Bornhäuser M., Ehninger G., et al. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia. Ann Hematol 2003, 82:336-342. 10.1007/s00277-003-0654-9.
    • (2003) Ann Hematol , vol.82 , pp. 336-342
    • Kröger, N.1    Bornhäuser, M.2    Ehninger, G.3
  • 2
    • 79956017109 scopus 로고    scopus 로고
    • Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS
    • Andersson B.S., Valdez B.C., de Lima M., et al. Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS. Biol Blood Marrow Transplant 2011, 17:893-900. 10.1016/j.bbmt.2010.09.022.
    • (2011) Biol Blood Marrow Transplant , vol.17 , pp. 893-900
    • Andersson, B.S.1    Valdez, B.C.2    de Lima, M.3
  • 3
    • 1842433581 scopus 로고    scopus 로고
    • Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome
    • Depil S., Deconinck E., Milpied N., et al. Donor lymphocyte infusion to treat relapse after allogeneic bone marrow transplantation for myelodysplastic syndrome. Bone Marrow Transplant 2004, 33:531-534. 10.1038/sj.bmt.1704381.
    • (2004) Bone Marrow Transplant , vol.33 , pp. 531-534
    • Depil, S.1    Deconinck, E.2    Milpied, N.3
  • 4
    • 58249126355 scopus 로고    scopus 로고
    • The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review
    • Oliansky D.M., Antin J.H., Bennett J.M., et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review. Biol Blood Marrow Transplant 2009, 15:137-172. 10.1016/j.bbmt.2008.12.003.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 137-172
    • Oliansky, D.M.1    Antin, J.H.2    Bennett, J.M.3
  • 5
    • 0034001270 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation
    • Yakoub-Agha I., de La Salmonière P., Ribaud P., et al. Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation. JClin Oncol 2000, 18:963-971.
    • (2000) JClin Oncol , vol.18 , pp. 963-971
    • Yakoub-Agha, I.1    de La Salmonière, P.2    Ribaud, P.3
  • 6
    • 33745968917 scopus 로고    scopus 로고
    • Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia
    • Cheson B.D., Greenberg P.L., Bennett J.M., et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 2006, 108:419-425. 10.1182/blood-2005-10-4149.
    • (2006) Blood , vol.108 , pp. 419-425
    • Cheson, B.D.1    Greenberg, P.L.2    Bennett, J.M.3
  • 7
    • 55149085208 scopus 로고    scopus 로고
    • New advances in hematopoietic cell transplantation
    • Petersdorf E.W., Hansen J.A. New advances in hematopoietic cell transplantation. Curr Opin Hematol 2008, 15:549-554. 10.1097/MOH.0b013e328311891f.
    • (2008) Curr Opin Hematol , vol.15 , pp. 549-554
    • Petersdorf, E.W.1    Hansen, J.A.2
  • 8
  • 9
    • 23744458895 scopus 로고    scopus 로고
    • Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française deGreffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study
    • Cahn J.-Y., Klein J.P., Lee S.J., et al. Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française deGreffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR) prospective study. Blood 2005, 106:1495-1500. 10.1182/blood-2004-11-4557.
    • (2005) Blood , vol.106 , pp. 1495-1500
    • Cahn, J.-Y.1    Klein, J.P.2    Lee, S.J.3
  • 10
    • 0023294094 scopus 로고
    • Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning
    • 1 Pt 3
    • Champlin R.E., Ho W.G., Mitsuyasu R., et al. Graft failure and leukemia relapse following T lymphocyte-depleted bone marrow transplants: effect of intensification of immunosuppressive conditioning. Transplant Proc 1987, 19(1 Pt 3):2616-2619.
    • (1987) Transplant Proc , vol.19 , pp. 2616-2619
    • Champlin, R.E.1    Ho, W.G.2    Mitsuyasu, R.3
  • 11
    • 0026049124 scopus 로고
    • T-cell depletion of HLA-identical transplants in leukemia
    • Marmont A.M., Horowitz M.M., Gale R.P., et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991, 78:2120-2130.
    • (1991) Blood , vol.78 , pp. 2120-2130
    • Marmont, A.M.1    Horowitz, M.M.2    Gale, R.P.3
  • 12
    • 34250777773 scopus 로고    scopus 로고
    • Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
    • Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 2007, 21:1387-1394. 10.1038/sj.leu.2404683.
    • (2007) Leukemia , vol.21 , pp. 1387-1394
    • Mohty, M.1
  • 13
    • 78149464225 scopus 로고    scopus 로고
    • Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire
    • Mohty M., Labopin M., Balère M.L., et al. Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire. Leukemia 2010, 24:1867-1874. 10.1038/leu.2010.200.
    • (2010) Leukemia , vol.24 , pp. 1867-1874
    • Mohty, M.1    Labopin, M.2    Balère, M.L.3
  • 14
    • 69249193742 scopus 로고    scopus 로고
    • Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
    • Finke J., Bethge W.A., Schmoor C., et al. Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 2009, 10:855-864. 10.1016/S1470-2045(09)70225-6.
    • (2009) Lancet Oncol , vol.10 , pp. 855-864
    • Finke, J.1    Bethge, W.A.2    Schmoor, C.3
  • 15
    • 33745449021 scopus 로고    scopus 로고
    • Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation
    • Bacigalupo A., Lamparelli T., Barisione G., et al. Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation. Biol Blood Marrow Transplant 2006, 12:560-565. 10.1016/j.bbmt.2005.12.034.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 560-565
    • Bacigalupo, A.1    Lamparelli, T.2    Barisione, G.3
  • 16
    • 84872926398 scopus 로고    scopus 로고
    • Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation
    • Blaise D., Tabrizi R., Boher J.-M., et al. Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation. Cancer 2013, 119:602-611. 10.1002/cncr.27786.
    • (2013) Cancer , vol.119 , pp. 602-611
    • Blaise, D.1    Tabrizi, R.2    Boher, J.-M.3
  • 17
    • 0036015540 scopus 로고    scopus 로고
    • Invivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors
    • Kröger N., Zabelina T., Krüger W., et al. Invivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors. Bone Marrow Transplant 2002, 29:683-689. 10.1038/sj.bmt.1703530.
    • (2002) Bone Marrow Transplant , vol.29 , pp. 683-689
    • Kröger, N.1    Zabelina, T.2    Krüger, W.3
  • 18
    • 79959456118 scopus 로고    scopus 로고
    • Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
    • Socie G., Schmoor C., Bethge W.A., et al. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood 2011, 117:6375-6382. 10.1182/blood-2011-01-329821.
    • (2011) Blood , vol.117 , pp. 6375-6382
    • Socie, G.1    Schmoor, C.2    Bethge, W.A.3
  • 19
    • 84891885113 scopus 로고    scopus 로고
    • Effective prevention of GVHD using invivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation
    • Wolschke C., Zabelina T., Ayuk F., et al. Effective prevention of GVHD using invivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation. Bone Marrow Transplant 2014, 49:126-130. 10.1038/bmt.2013.143.
    • (2014) Bone Marrow Transplant , vol.49 , pp. 126-130
    • Wolschke, C.1    Zabelina, T.2    Ayuk, F.3
  • 20
    • 19044374259 scopus 로고    scopus 로고
    • Invivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study
    • Bonifazi F., Bandini G., Stanzani M., et al. Invivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study. Bone Marrow Transplant 2005, 35:1025-1026. 10.1038/sj.bmt.1704940.
    • (2005) Bone Marrow Transplant , vol.35 , pp. 1025-1026
    • Bonifazi, F.1    Bandini, G.2    Stanzani, M.3
  • 21
    • 79959496711 scopus 로고    scopus 로고
    • Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies
    • Soiffer R.J., Lerademacher J., Ho V., et al. Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Blood 2011, 117:6963-6970. 10.1182/blood-2011-01-332007.
    • (2011) Blood , vol.117 , pp. 6963-6970
    • Soiffer, R.J.1    Lerademacher, J.2    Ho, V.3
  • 22
    • 84895727587 scopus 로고    scopus 로고
    • Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas
    • [Epub ahead of print], Nov 8
    • De Masson A., Beylot-Barry M., Bouaziz J.-D., et al. Allogeneic stem cell transplantation for advanced cutaneous T-cell lymphomas: a study from the French Society of Bone Marrow Transplantation and French Study Group on Cutaneous Lymphomas. Haematologica 2013 Nov 8, [Epub ahead of print]. 10.3324/haematol.2013.098145.
    • (2013) Haematologica
    • De Masson, A.1    Beylot-Barry, M.2    Bouaziz, J.-D.3
  • 23
    • 0017162163 scopus 로고
    • Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group
    • Bennett J.M., Catovsky D., Daniel M.T., et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976, 33:451-458.
    • (1976) Br J Haematol , vol.33 , pp. 451-458
    • Bennett, J.M.1    Catovsky, D.2    Daniel, M.T.3
  • 24
    • 84885814226 scopus 로고    scopus 로고
    • Myelodysplastic syndromes/neoplasms: recent classification system based on World Health Organization Classification of Tumors - International Agency for Research on Cancer for Hematopoietic and Lymphoid Tissues
    • Gupta G., Singh R., Kotasthane D.S., Kotasthane V.D. Myelodysplastic syndromes/neoplasms: recent classification system based on World Health Organization Classification of Tumors - International Agency for Research on Cancer for Hematopoietic and Lymphoid Tissues. JBlood Med 2010, 1:171-182. 10.2147/JBM.S12257.
    • (2010) JBlood Med , vol.1 , pp. 171-182
    • Gupta, G.1    Singh, R.2    Kotasthane, D.S.3    Kotasthane, V.D.4
  • 25
    • 0030897009 scopus 로고    scopus 로고
    • International scoring system for evaluating prognosis in myelodysplastic syndromes
    • Greenberg P., Cox C., LeBeau M.M., et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1997, 89:2079-2088.
    • (1997) Blood , vol.89 , pp. 2079-2088
    • Greenberg, P.1    Cox, C.2    LeBeau, M.M.3
  • 26
    • 0034554786 scopus 로고    scopus 로고
    • Report of an international working group to standardize response criteria for myelodysplastic syndromes
    • Cheson B.D., Bennett J.M., Kantarjian H., et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood 2000, 96:3671-3674.
    • (2000) Blood , vol.96 , pp. 3671-3674
    • Cheson, B.D.1    Bennett, J.M.2    Kantarjian, H.3
  • 27
    • 84906320628 scopus 로고    scopus 로고
    • Prophylaxie de la réaction aiguë du greffon contre l'hÔte
    • Bay J.-O., Dalle J.-H., Dhedin N., et al. Prophylaxie de la réaction aiguë du greffon contre l'hÔte. Hématologie 2011, 17:15-17.
    • (2011) Hématologie , vol.17 , pp. 15-17
    • Bay, J.-O.1    Dalle, J.-H.2    Dhedin, N.3
  • 29
    • 1542532754 scopus 로고    scopus 로고
    • Aproportional hazards model for the subdistribution of a competing risk
    • Fine J., Gray R.J. Aproportional hazards model for the subdistribution of a competing risk. JAm Stat Assoc 1999, 94:496-509.
    • (1999) JAm Stat Assoc , vol.94 , pp. 496-509
    • Fine, J.1    Gray, R.J.2
  • 30
    • 3543135271 scopus 로고    scopus 로고
    • Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group
    • D'Agostino R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998, 17:2265-2281.
    • (1998) Stat Med , vol.17 , pp. 2265-2281
    • D'Agostino, R.B.1
  • 31
    • 37349118061 scopus 로고    scopus 로고
    • High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
    • Lee S.J., Klein J., Haagenson M., et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007, 110:4576-4583. 10.1182/blood-2007-06-097386.
    • (2007) Blood , vol.110 , pp. 4576-4583
    • Lee, S.J.1    Klein, J.2    Haagenson, M.3
  • 32
    • 34247163959 scopus 로고    scopus 로고
    • Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy
    • Yakoub-Agha I., Mesnil F., Kuentz M., et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. JClin Oncol 2006, 24:5695-5702. 10.1200/JCO.2006.08.0952.
    • (2006) JClin Oncol , vol.24 , pp. 5695-5702
    • Yakoub-Agha, I.1    Mesnil, F.2    Kuentz, M.3
  • 33
    • 38349195008 scopus 로고    scopus 로고
    • Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission
    • Martino R., Valcárcel D., Brunet S., et al. Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission. Bone Marrow Transplant 2008, 41:33-38. 10.1038/sj.bmt.1705879.
    • (2008) Bone Marrow Transplant , vol.41 , pp. 33-38
    • Martino, R.1    Valcárcel, D.2    Brunet, S.3
  • 34
    • 0033971243 scopus 로고    scopus 로고
    • Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle
    • Blaise D., Kuentz M., Fortanier C., et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle. JClin Oncol 2000, 18:537-546.
    • (2000) JClin Oncol , vol.18 , pp. 537-546
    • Blaise, D.1    Kuentz, M.2    Fortanier, C.3
  • 35
    • 0036682921 scopus 로고    scopus 로고
    • Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia
    • Schmitz N., Beksac M., Hasenclever D., et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002, 100:761-767. 10.1182/blood-2001-12-0304.
    • (2002) Blood , vol.100 , pp. 761-767
    • Schmitz, N.1    Beksac, M.2    Hasenclever, D.3
  • 36
    • 0038156372 scopus 로고    scopus 로고
    • Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen
    • Mohty M., Bay J.-O., Faucher C., et al. Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen. Blood 2003, 102:470-476. 10.1182/blood-2002-12-3629.
    • (2003) Blood , vol.102 , pp. 470-476
    • Mohty, M.1    Bay, J.-O.2    Faucher, C.3
  • 37
    • 1542577210 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation
    • Waller E.K., Langston A.A., Lonial S., et al. Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation. Biol Blood Marrow Transplant 2003, 9:460-471.
    • (2003) Biol Blood Marrow Transplant , vol.9 , pp. 460-471
    • Waller, E.K.1    Langston, A.A.2    Lonial, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.